Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET

Michael G. Doran; Philip A. Watson; Sarah M. Cheal; Daniel E. Spratt; John Wongvipat; Jeffrey M. Steckler; Jorge A. Carrasquillo; Michael J. Evans; Jason S. Lewis

doi:10.2967/jnumed.114.145185

Research ArticleBasic Science Investigations

Annotating STEAP1 Regulation in Prostate Cancer with ⁸⁹Zr Immuno-PET

Michael G. Doran, Philip A. Watson, Sarah M. Cheal, Daniel E. Spratt, John Wongvipat, Jeffrey M. Steckler, Jorge A. Carrasquillo, Michael J. Evans and Jason S. Lewis

Journal of Nuclear Medicine December 2014, 55 (12) 2045-2049; DOI: https://doi.org/10.2967/jnumed.114.145185

Michael G. Doran

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philip A. Watson

2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sarah M. Cheal

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel E. Spratt

3Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John Wongvipat

2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeffrey M. Steckler

2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jorge A. Carrasquillo

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Evans

2Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jason S. Lewis

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

4Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 55, Issue 12

December 1, 2014

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Annotating STEAP1 Regulation in Prostate Cancer with 89Zr Immuno-PET

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Annotating STEAP1 Regulation in Prostate Cancer with ⁸⁹Zr Immuno-PET

Michael G. Doran, Philip A. Watson, Sarah M. Cheal, Daniel E. Spratt, John Wongvipat, Jeffrey M. Steckler, Jorge A. Carrasquillo, Michael J. Evans, Jason S. Lewis

Journal of Nuclear Medicine Dec 2014, 55 (12) 2045-2049; DOI: 10.2967/jnumed.114.145185

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Annotating STEAP1 Regulation in Prostate Cancer with ⁸⁹Zr Immuno-PET

Michael G. Doran, Philip A. Watson, Sarah M. Cheal, Daniel E. Spratt, John Wongvipat, Jeffrey M. Steckler, Jorge A. Carrasquillo, Michael J. Evans, Jason S. Lewis

Journal of Nuclear Medicine Dec 2014, 55 (12) 2045-2049; DOI: 10.2967/jnumed.114.145185

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates
Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)
Structural basis for targeting human cancer antigen STEAP1 with antibodies
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Microfluidic Preparation of a 89Zr-Labeled Trastuzumab Single-Patient Dose

Google Scholar

Keywords

PET
prostate cancer
androgen receptor

Main menu

User menu

Search

Annotating STEAP1 Regulation in Prostate Cancer with ⁸⁹Zr Immuno-PET

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords